Apogee Therapeutics Inc (NASDAQ:APGE)’s traded shares stood at 0.63 million during the last session, with the company’s beta value hitting 1.63. At the close of trading, the stock’s price was $39.84, to imply a decrease of -1.31% or -$0.53 in intraday trading. The APGE share’s 52-week high remains $71.75, putting it -80.1% down since that peak but still an impressive 26.96% since price per share fell to its 52-week low of $29.10. The company has a valuation of $2.37B, with an average of 0.76 million shares in intraday trading volume over the past 10 days and average of 587.02K shares over the past 3 months.
Apogee Therapeutics Inc (NASDAQ:APGE) trade information
After registering a -1.31% downside in the last session, Apogee Therapeutics Inc (APGE) has traded red over the past five days. The 5-day price performance for the stock is -0.25%, and 17.35% over 30 days. With these gigs, the year-to-date price performance is -12.05%. Short interest in Apogee Therapeutics Inc (NASDAQ:APGE) saw shorts transact 7.76 million shares and set a 14.34 days time to cover.
The extremes give us $95 and $95 for target low and target high price respectively. As such, APGE has been trading -138.45% off suggested target high and -138.45% from its likely low.
APGE Dividends
Apogee Therapeutics Inc has its next earnings report out on 2025-Mar-02. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Apogee Therapeutics Inc (NASDAQ:APGE)’s Major holders
Apogee Therapeutics Inc insiders hold 11.36% of total outstanding shares, with institutional holders owning 130.16% of the shares at 146.85% float percentage. In total, 130.16% institutions holds shares in the company, led by VR ADVISER, LLC. As of 2024-06-30, the company held over 8.49 million shares (or 15.0284% of shares), all amounting to roughly $334.21 million.
The next major institution holding the largest number of shares is WELLINGTON MANAGEMENT GROUP LLP with 3.55 million shares, or about 6.2761% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $139.57 million.
We also have Vanguard Health Care Fund and Fidelity Growth Company Fund as the top two Mutual Funds with the largest holdings of the Apogee Therapeutics Inc (APGE) shares. Going by data provided on Oct 31, 2024 , Vanguard Health Care Fund holds roughly 2.0 shares. This is just over 4.44% of the total shares, with a market valuation of $79.68 million. Data from the same date shows that the other fund manager holds a little less at 1.41, or 3.12% of the shares, all valued at about 56.03 million.
